Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2005-10-04
2005-10-04
Myers, Carla J. (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C435S091200, C536S023100, C536S023500, C536S024310
Reexamination Certificate
active
06951721
ABSTRACT:
Methods for identifying functional allele profiles of a given gene are disclosed. Functional allele profiles comprise the commonly occurring alleles in a population, and the relative frequencies at which such alleles of a given gene occur. Functional allele profiles are useful in treatment and diagnosis of diseases, for genetic and pharmacogenetic applications and for evaluating the degree to which the gene(s) are under selective pressure.
REFERENCES:
patent: 4458066 (1984-07-01), Caruthers et al.
patent: 5498324 (1996-03-01), Yeung et al.
patent: 5561058 (1996-10-01), Gelfand et al.
patent: 5578443 (1996-11-01), Santamaria et al.
patent: 5593840 (1997-01-01), Bhatnagar et al.
patent: 5642936 (1997-07-01), Evans
patent: 5654155 (1997-08-01), Murphy et al.
patent: 5686246 (1997-11-01), Kornman et al.
patent: 5750400 (1998-05-01), Murphy et al.
patent: 5763183 (1998-06-01), Pesonen et al.
patent: 0 699 754 (1996-03-01), None
patent: 0 705 902 (1996-04-01), None
patent: 0 705 903 (1996-04-01), None
patent: WO 95/19369 (1995-07-01), None
patent: WO 98/05677 (1998-02-01), None
patent: WO 98/44157 (1998-10-01), None
Beaucage et al., “Deoxynucleoside Phosphoramidites—A New Class of Key Intermediates for Deoxypolynucleotide Synthesis,”Tetrahedron Letters 22(20):1859-1862 (1981).
Beutler et al., “Molecular Heterogeneity of Glucose-6-Phosphate Dehydrogenase A,”Blood 74(7):2550-2555 (1989).
Beutler et al., “Mutation analysis of glucose-6-phosphate dehydrogenase (G6PD) variants in Costa Rica,”Human Genetics 87:462-464 (1991).
Connor et al., “Detection of sickle cell βS-globin allele by hybridization with synthetic oligonucleotides,”Proc, Natl. Acad. Sci. U.S.A. 80:278-282 (1983).
Cooke et al., “PlA2polymorphism and efficcy of aspirin,”The Lancet 351:1253 (1998).
Couch et al., “Mutations and Polymorphisms in the Familial Early-Onset Breast Cancer (BRCA1) Gene),”Human Mutation 8:8-18 (1996).
Dunning et al., “Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population,”Human Molecular Genetics 6(2):285-289 (1997).
Durocher et al., “Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations,”Human Molecular Genetics 5(6):835-842 (1996).
Easton et al., “Genetic Linkage Analysis in Familial Breast and Ovarian Cancer: Results from 214 Families,”American Journal of Human Genetics 52:678-701 (1993).
Friedman et al., “Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families,”Nature Genetics 8:399-404 (1994).
Friend et al., Breast cancer information on the web,Nature Genetics 11:238-239 (1995).
Hirono, A. and Beutler, E., “Molecular cloning and nucleotide sequence of cDNA for human glucose-6-phosphate dehydrogenase variant A(-),”Proc. Natl. Acad. Sci. U.S.A. 85:3951-3954 (1988).
Holt et al., “Growth retardation and tumour inhibition by BRCA1,”Nature Genetics 12(3):298-302 (1996).
Landgren et al., “A Ligase-Mediated Gene Detection Technique,”Science 241:1077-1021 (1988).
Landgren et al., “DNA Diagnostics—Molecular Techniques and Automation,”Science 242:229-237 (1988).
Liaw et al., “Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome,”Nature Genetics 16(1):64-67 (1997).
Maniatis et al.,Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, NY, pp. 280-281 (1982).
Miki et al., “A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1,”Science 266:66-71 (1994).
Newman et al., “The Human Platelet Alloantigens, PlA1and PlA2Are Associated with a Leucine33/Proline33Amino Acid Polymorphism in Membrane Glycoprotein IIIa, and Are Distinguishable by DNA Typing,”Journal of Clinical Investigation 83:1778-1781 (1989).
PCR, A Practical Approach, ILR Press, Eds. M.J. McPherson, P. Quirke, and G.R. Taylor (1992).
Ridker et al., “PlA1/A2polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis,”The Lancet 349:385-388 (1997).
Saiki et al., “A Novel Method for the Detection of Polymorphic Restriction Sites by Cleavage of Oligonucleotide Probes: Application to Sickle-Cell Anemia,”Bio/Technology 3:1008-1012 (1985).
Sambrook et al.,Molecular Cloning, A Laboratory Manual, 2ndEd.; Cold Spring Harbor Laboratory Press, at 9.16-9.19 (1989).
Sharan et al., “Murine Brce1: sequence and significance for human missense mutations,”Human Molecular Genetics 4(12):2275-2278 (1995).
Shuldiner et al.,Handbook of Endocrine Research Techniques, de Pablo, F., Scanes, C., and Weintraub, B., eds., Academic Press, Inc., pp. 457-486 (1993).
Storey et al., “Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer,”Nature 393:229-234 (1998).
Vogelstein et al., “p53 Function and Dysfunction,”Cell 70:523-526 (1992).
Weiss et al., “A monoclonal antibody (SZ21) specific for platelet GPIIIa distinguishes P1A1from P1A2,”Tissue Antigens 46:374-381 (1995).
Weiss et al., “A Polymorphism of a Platelet Glycoprotein Receptor as an Inherited Risk Factor for Coronary Thrombosis,”The New England Journal of Medicine 334(17):1090-1094 (1996).
Molecular Biology, 2d ed., David Freifelder, auth., Jones and Bartlett Publishers, Inc. Boston, p. 37 (1987).
Mattila, P. et al., “Extensive Allelic Sequence Variation in the J Region of the Human Immunoglobulin Heavy Chain Gene Locus”,Eur. J. Immunol.—25:2578-2582 (1995).
Morrison, N., et al., “Frequent Alleles of the Human Vitamin D Receptor Gene Are Functionally Distinct”,Garvan Institute of Medical Research—20(Feb. 21, 1992).
Moudallal, J., et al., “Monoclonal Antibodies as Probes of the Antigenic Structure of Tobacco Mosaic Virus”,The EMBO Journal—1(8):1005-1010 (1982).
Hacia, J., et al., “Detection of Heterozygous Mutations in BRCA1 Using High Density Oligonucleotide Arrays and Two-Colour Fluorescence Analysis”,Nature Genetics 14:441-447 (Dec. 1996).
Merajver, S., et al., “Risk Assessment and Presymptomatic Molecular Diagnosis in Hereditary Breast Cancer”,DNA Technology—16(1):139-137 (Mar. 1996).
Madsen, H., et al., “A New Frequent Allele is the Missing Link in the Structural Polymorphism of the Human Mannan-Binding Protein”,Immunogenetics—40:37-44 (1994).
Wainscoat, J., et al., “Evolutionary Relationships of Human Populations From an Analysis of Nuclear DNA Polymorphisms”,Nature—319:491-493 (Feb. 6, 1986).
Gene Logic Inc.
Morgan & Lewis & Bockius, LLP
Myers Carla J.
LandOfFree
Method for determining the haplotype of a human BRCA1 gene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for determining the haplotype of a human BRCA1 gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for determining the haplotype of a human BRCA1 gene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3477991